A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
Public ClinicalTrials.gov record NCT00290134. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Preliminary Efficacy and Safety of Fispemifene in the Treatment of Hypogonadism: A 4 Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Daily Oral Doses of 100, 200, and 300 mg Fispemifene and Placebo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether one or more fispemifene dose regimens are more effective than placebo in the treatment of hypogonadism in older men.
Study identification
- NCT ID
- NCT00290134
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2007 (Actual)
- Last update posted
- Mar 3, 2008
2006 – 2007
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site | Huntsville | Alabama | 35801 | — |
| Clinical Research Site | Modesto | California | 95350 | — |
| Clinical Research Site | Aurora | Colorado | 80012 | — |
| Clinical Research Site | Waterbury | Connecticut | 06708 | — |
| Clinical Research Site | New Port Richey | Florida | 34652 | — |
| Clinical Research Site | Tallahassee | Florida | 32308 | — |
| Clinical Research Site | Peoria | Illinois | 61614 | — |
| Clinical Research Site | Greenbelt | Maryland | 20770 | — |
| Clinical Research Site | Las Vegas | Nevada | 89109 | — |
| Clinical Research Site | Garden City | New York | 11530 | — |
| Clinical Research Site | Poughkeepsie | New York | 12601 | — |
| Clinical Research Site | Williamsville | New York | 14221 | — |
| Clinical Research Site | Bethany | Oklahoma | 73008 | — |
| Clinical Research Site | Greer | South Carolina | 29650 | — |
| Clinical Research Site | San Antonio | Texas | 78229 | — |
| Clinical Research Site | Seattle | Washington | 98166 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00290134, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2008 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00290134 live on ClinicalTrials.gov.